Above: Rep. Robin Lundstrum (R — Springdale) explains the SAFE Act to the Arkansas House of Representatives in this file photo from 2021.

The federal lawsuit over Arkansas’ Save Adolescents From Experimentation (SAFE) Act will go trial at 9:00 AM on Monday, October 17, 2022. The U.S. District Court’s schedule indicates the trial will last all day, with Judge James Moody presiding over the case.

The SAFE Act is an excellent law that protects children from sex-reassignment procedures, puberty blockers, and cross-sex hormones.

The Arkansas Legislature overwhelmingly passed the Save Adolescents From Experimentation (SAFE) Act last year.

Researchers do not know the long term effects that puberty blockers and cross-sex hormones can have on kids.

The U.S. Food and Drug Administration has never approved puberty blockers and cross-sex hormones for the purpose of gender transition. Doctors are giving these hormones to kids off-label, in a manner the FDA never intended.

In July the U.S. Food and Drug Administration added a warning label to puberty blockers after biological girls developed symptoms of tumor-like masses in the brain.

In 2021 a major hospital in Sweden made headlines after announcing it would no longer administer puberty blockers and cross-sex hormones to children.

Over the summer news broke that a U.K. gender clinic that prescribed puberty blockers and cross-sex hormones to children for many years now faces the possibility of lawsuits from upwards of 1,000 families.

Despite mounting evidence that sex-change hormones and procedures are not appropriate for children, the ACLU and others have asked the federal courts to strike down Arkansas’ SAFE Act.

Several business interests and the Biden-Harris Administration also have joined the fight against Arkansas’ SAFE Act.

The lawsuit over the SAFE Act has underscored several key points about gender dysphoria, including:

  • The science surrounding gender identity remain in flux.
  • The demographics of transgender youth is changing in ways that scientists do not yet understand.
  • Randomized clinical trials do not support the adolescent gender transition processes that many doctors in America use.

U.S. District Judge James Moody has temporarily blocked the state from enforcing the law while the lawsuit progresses. 

Arkansas’ SAFE Act protects children. We believe federal courts ultimately will recognize that fact and uphold this good law as constitutional.